STK38 and metabolic syndrome: A liver-specific KO of Stk38 ameliorated high-fat-died (HFD) induced insulin resistance, hepatic inflammation, and lipid accumulation, as well as can reduce the cholesterol and triacylglycerol (TAG) levels (Rawat et al., 2023), which are major indicators of metabolic syndrome.